Aemetis (NASDAQ:AMTX) Issues Earnings Results

Aemetis (NASDAQ:AMTXGet Free Report) issued its quarterly earnings results on Tuesday. The specialty chemicals company reported ($0.38) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.47) by $0.09, Zacks reports. The firm had revenue of $81.44 million for the quarter, compared to the consensus estimate of $77.79 million. During the same period in the previous year, the business posted ($0.59) earnings per share.

Aemetis Trading Down 10.6 %

Shares of AMTX stock opened at $4.13 on Thursday. The stock’s fifty day simple moving average is $2.73 and its 200-day simple moving average is $3.06. The company has a market capitalization of $194.92 million, a price-to-earnings ratio of -1.83 and a beta of 1.23. Aemetis has a 1-year low of $2.10 and a 1-year high of $7.03.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. HC Wainwright reiterated a “buy” rating and issued a $28.00 price target on shares of Aemetis in a research report on Friday, August 2nd. Truist Financial reiterated a “hold” rating and issued a $3.50 target price (down from $4.00) on shares of Aemetis in a report on Wednesday, July 31st. StockNews.com raised shares of Aemetis to a “sell” rating in a research note on Wednesday, July 31st. Ascendiant Capital Markets decreased their price target on shares of Aemetis from $20.00 to $19.00 and set a “buy” rating on the stock in a research report on Tuesday, September 3rd. Finally, UBS Group cut their price objective on Aemetis from $8.25 to $7.75 and set a “buy” rating for the company in a research report on Monday, August 19th. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $12.95.

Read Our Latest Research Report on AMTX

Aemetis Company Profile

(Get Free Report)

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.

Read More

Earnings History for Aemetis (NASDAQ:AMTX)

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.